Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 91301-91350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05127226
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
PHASE1/PHASE2Recruiting
70 participants
Started: Dec 22, 2021 · Completed: Mar 31, 2029
1 condition1 sponsor11 locations
NCT05188092
Lung Ultrasound-Guided Fluid Deresuscitation in ICU Patients
NARecruiting
1,000 participants
Started: Dec 22, 2021 · Completed: Dec 1, 2025
4 conditions2 sponsors3 locations
NCT06420843
Microbiota, Metabolome and Nutrition: an 'Artificially Intelligent' Way to Personalized Nutrition
NARecruiting
48 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05191381
Immune Modulation by Exosomes in COVID-19
N/ARecruiting
40 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05166850
Preventative Intervention for Cholera for 7 Days
NARecruiting
2,900 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
3 conditions3 sponsors2 locations
NCT05051891
A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma
PHASE3Recruiting
356 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor22 locations
NCT05145907
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
PHASE2Active, not recruiting
133 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor20 locations
NCT05117619
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
NARecruiting
440 participants
Started: Dec 22, 2021 · Completed: May 30, 2026
1 condition5 sponsors1 location
NCT06856993
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
N/ARecruiting
300 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05184816
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
PHASE1Recruiting
35 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors7 locations
NCT05269394
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
PHASE2/PHASE3Active, not recruiting
197 participants
Started: Dec 22, 2021 · Completed: Jul 31, 2028
3 conditions5 sponsors38 locations
NCT05113069
A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas
PHASE1Enrolling by invitation
170 participants
Started: Dec 22, 2021 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT05054439
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
PHASE2Active, not recruiting
42 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT06571955
ACL Reconstruction with a New Generation of LARS Artificial Ligament
NAActive, not recruiting
40 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04685590
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
PHASE2Active, not recruiting
48 participants
Started: Dec 22, 2021 · Completed: Jan 31, 2029
2 conditions3 sponsors5 locations
NCT05890456
Students With Involved Families and Teachers
NARecruiting
320 participants
Started: Dec 22, 2021 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT04965519
A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies
PHASE2Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05153772
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
PHASE2Active, not recruiting
69 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2028
1 condition2 sponsors4 locations
NCT05209620
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
PHASE2Recruiting
30 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT04947384
Pulmonary Vascular Hemodynamics Before and After Mitral Valve Procedures
N/ARecruiting
120 participants
Started: Dec 21, 2021 · Completed: Jan 20, 2026
1 condition1 sponsor1 location
NCT05228470
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
PHASE2Active, not recruiting
39 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2025
11 conditions1 sponsor15 locations
NCT04958811
Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC
PHASE2Active, not recruiting
29 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT04997811
Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes
PHASE2Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jun 30, 2025
1 condition6 sponsors19 locations
NCT05165979
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil
N/AActive, not recruiting
650 participants
Started: Dec 21, 2021 · Completed: Jul 1, 2024
4 conditions1 sponsor24 locations
NCT05098613
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
PHASE1Recruiting
20 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05068388
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
PHASE2Active, not recruiting
240 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05800925
Triage Survey for Psychiatry Research Eligibility
N/ARecruiting
2,000 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT06323278
Effectiveness of Cognitive Stimulation Treatment in Patients With Parkinson's Disease
N/ARecruiting
68 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05553886
S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction
PHASE3Recruiting
5 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05031078
Assessing Durable Antibody Response to HPV Vaccination
PHASE4Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: May 31, 2026
1 condition1 sponsor2 locations
NCT05068544
Adolescent Normative Sport Movement Analysis
N/ARecruiting
40 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05130827
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
PHASE2Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT05115474
Study of Screening Brain MRIs in Stage IV Breast Cancer
N/ARecruiting
170 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2026
3 conditions2 sponsors2 locations
NCT05141201
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)
N/AActive, not recruiting
1,620 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor47 locations
NCT05979675
Acute Myeloid Leukemia Registry
N/ARecruiting
250 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT06124599
Prodromes of Menstrual Staphylococcal Toxic Shock
N/ARecruiting
316 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT05621343
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
N/ARecruiting
130 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05521503
Biopsy Collection and Repository Database
N/ARecruiting
400 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04905069
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
NAActive, not recruiting
500 participants
Started: Dec 21, 2021 · Completed: Apr 30, 2030
1 condition1 sponsor30 locations
NCT04919226
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
PHASE3Active, not recruiting
259 participants
Started: Dec 21, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor42 locations
NCT05074420
A Study of Baricitinib (LY3009104) in Children With COVID-19
PHASE3Recruiting
24 participants
Started: Dec 21, 2021 · Completed: May 31, 2026
2 conditions1 sponsor14 locations
NCT05154799
Developmental Coordination Disorder
NARecruiting
280 participants
Started: Dec 21, 2021 · Completed: Jan 21, 2027
2 conditions1 sponsor1 location
NCT05145062
Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.
N/AEnrolling by invitation
12 participants
Started: Dec 21, 2021 · Completed: Jul 14, 2038
1 condition1 sponsor7 locations
NCT05197036
A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
N/AActive, not recruiting
299 participants
Started: Dec 21, 2021 · Completed: Dec 25, 2028
3 conditions1 sponsor21 locations
NCT04572880
Evaluation of Minimal Invasive Glaucoma Surgery
NARecruiting
150 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05155137
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
PHASE3Recruiting
8,518 participants
Started: Dec 20, 2021 · Completed: Dec 14, 2030
2 conditions3 sponsors2 locations
NCT05159193
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
PHASE3Recruiting
372 participants
Started: Dec 20, 2021 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT04533750
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
PHASE1Active, not recruiting
42 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
18 conditions2 sponsors27 locations
NCT04769206
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
PHASE1/PHASE2Recruiting
88 participants
Started: Dec 20, 2021 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT05464849
Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension
N/ARecruiting
150 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location